Back

Benefit of betablockers in patients with heart failure and right ventricular dysfunction: insights from the FRESH multicentre study

28 August 2026 (10:00 - 10:10)
Organised by: Logo
Congress Presentation Part of: High-risk heart failure: when to optimise, when to escalate, when to support? Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Charles Fauvel

University Hospital of Rouen, Rouen (France)

4 More presentations in this session

Presentation thumbnail
Association between heart failure medical therapy and clinical outcomes after durable left ventricular assist device implantation
Doctor T. Kondo (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
Multidisciplinary cardiac case conference overcomes therapeutic inertia in heart failure: achieving guideline-directed therapy in high-risk populations
Doctor N. Sowden (Brisbane, AU)
Abstract Slides Video
Presentation thumbnail
Temporal trends in guideline-directed medical therapy adoption in heart failure: insights from the iCaReMe global registry
Professor R. Silva Tinoco (Ciudad de Mexico, MX)
Abstract Slides Video
Presentation thumbnail
Pulmonary arterial elastance after LVAD implantation as a predictor of late right ventricular failure beyond six months of support
Mrs E. Karapedi (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
High-risk heart failure: when to optimise, when to escalate, when to support?
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Role of SGLT2I in improving right ventricular systolic function in patients with HFpEF
28 August 2026
thumbnail
Congress Presentation
Do all heart failure patients really ned beta-blockers?
1 September 2025
thumbnail
Congress Session
Daily Highlights by the Algerian Society of Cardiology
2 September 2024
thumbnail
Congress Presentation
Prognostic impact of right ventricular global wasted work in acute heart failure with right ventricular dysfunction
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources